Canterbury DHB

Context

Introduction

Allo-antibodies to factor VIII occur in 10 to 15% of patients with classical haemophilia (usually < 10% FVIII level) and usually within the first 40 treatment-exposure days. Inhibitors do not occur after 200 treatment-exposure days. Factor IX antibodies are extremely rare.

Information Required

About this Canterbury DHB document (5268):

Document Owner:

Not assigned (see Who's Who)

Last Reviewed:

November 2019

Next Review:

November 2022

Keywords:

Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 5268